泌尿外科改良马卡里皮肤试验——有意义吗？

Br J Urol. 1977;49(7):569-73. doi: 10.1111/j.1464-410x.1977.tb04533.x.

The Makari test is able to detect the presence of cancer in 95% of patients with primary tumours having excluded anergic patients. The test is useful in monitoring primary treatment. A long-term follow-up is necessary to determine the reason for patients' unexplained positive reactions in a control group of patients.

马卡里检测能够在排除无反应患者后，在95%的原发性肿瘤患者中检测出癌症。该检测对监测初始治疗很有用。有必要进行长期随访，以确定对照组患者出现无法解释的阳性反应的原因。